Martha Gulati/www.womenheart.org; Annalisa Filtz, Leandro Slipczuk/LinkedIn
Mar 21, 2026, 11:34
Martha Gulati: How Does Lp(a) Drive Atherosclerosis?
Martha Gulati, Director of the Davis Women Heart Center at Houston Methodist DeBakey Heart and Vascular Center, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“How does Lp(a) drive atherosclerosis?
- Delivers cholesterol to the arterial wall
- Carries oxidized phospholipids, leading to vascular inflammation
- Interferes with plasminogen, resulting in impaired fibrinolysis
- Promotes an atherothrombotic environment
Understanding these mechanisms strengthens the case for targeted Lp(a) therapies.”
Title: Presumed Mechanisms Underlying Lipoprotein(a)-caused Atherosclerosis
Authors: Annalisa Filtz, Leandro Slipczuk, Martha Gulati
Read the Full Article on ECR Journal.
Stay updated on all scientific advances with Hemostasis Today.
-
May 13, 2026, 15:38International Journal of Stroke: Oral Anticoagulants and DOAC–Antiplatelet Therapy Are Associated with Increased Major Bleeding Risk
-
May 13, 2026, 15:19Papa Heme։ Causes of Isolated Prolonged aPTT Without Bleeding
-
May 13, 2026, 15:10Wolfgang Miesbach: Rethinking Bleeding Risk in Anticoagulation
-
May 13, 2026, 15:09Veronica Sanchez: Better Cardiovascular Health Helps Lower Heart Attack Risk
-
May 13, 2026, 15:07Tung Nguyen Thanh: New Perspective on Thrombosis in Hematological Malignancies in Vietnam
-
May 13, 2026, 15:03Haji Siyamuddin Ansari: The Key Difference Between Plasma and Serum
-
May 13, 2026, 14:45Masoabi Sefojane: The Cost of a 35-Year Diagnosis Delay
-
May 13, 2026, 14:39Ahmed Mohsen: Managing DVT During Pregnancy and Lactation
-
May 13, 2026, 14:38The Coffee Shop Origins of Factor V Leiden – ISTH